Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 951 of 5804
-
Experimental drug combo targets Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of pidnarulex in combination with trastuzumab deruxtecan in treating patients with breast cancer and other solid tumors that express varying levels of a protein called HER2 and that has spread from where it first st…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New heart surgery technique aims to stop AFib in its tracks
Disease control Not yet recruitingAtrial Fibrillation (AF) is the most common cardiac arrhythmia worldwide, affecting approximately 2.8% of the population, with prevalence increasing with age. AF is associated with significant morbidity and mortality, accounting for about 25% of ischemic strokes, 10% of cryptogen…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New scan could spot hidden cancers in the belly
Diagnosis Recruiting nowThis study is a Phase 2/3, prospective, multicenter, open-label, non-randomized clinical trial, in which GEH300079 (68Ga) PET/CT images will be acquired in patients with primary colorectal, gastric, ovarian, or Pancreatic Ductal Adenocarcinoma (PDAC) cancers and known or suspecte…
Phase: PHASE2, PHASE3 • Sponsor: GE Healthcare • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Can green tea and quercetin boost chemo for advanced prostate cancer?
Disease control Recruiting nowThe goal of this clinical trial is to find out if taking natural products green tea and quercetin along with docetaxel chemotherapy improves the therapy of advanced prostate cancer, i.e., metastatic castration-resistant prostate cancer (mCRPC). It will also learn about the safety…
Phase: PHASE1, PHASE2 • Sponsor: Charles Drew University of Medicine and Science • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
AI steps in to stop pain before it becomes chronic after surgery
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether a pain-management program called a Transitional Pain Service can help prevent long-term pain and reduce opioid needs after surgery in adult surgical patients who may be at higher risk for developing persistent pain. The main que…
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New asthma inhaler faces off against standard treatment in major trial
Disease control Not yet recruitingThis is a Phase 3, multicenter, randomized, parallel-group, open-label, non-inferiority clinical trial designed to evaluate the efficacy and safety of N0783 compared to Alenia® (Formoterol 6 mcg / Budesonide 200 mcg) in the treatment of moderate asthma. Adult patients diagnosed w…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blood test may spare some women from radiation after endometrial cancer surgery
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to assess if circulating tumor DNA can guide adjuvant selection in high-intermediate risk early-stage endometrial cancer. The main question it aims to answer is: • To evaluate if 3-year recurrence-free survival among women with Stage I, high-in…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New polymer plug aims to prevent deadly aortic growth in first human trial
Disease control Not yet recruitingTo determine the safety and feasibility of investigational product to reduce aortic dissection false lumen perfusion.
Phase: NA • Sponsor: Shape Memory Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study tests best way to deliver antibiotics for sepsis
Disease control Not yet recruitingThis observational study compares extended versus intermittent beta-lactam infusion in sepsis patients, assessing survival, clinical cure rates, and practical ICU challenges. The findings will guide optimal antibiotic protocols, potentially improving sepsis outcomes through preci…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a bile acid and herbal mix treat Diabetes-Related vision loss?
Disease control Not yet recruitingDiabetic macular edema is seen in the later stages of diabetic retinopathy with current conventional therapies targeting local vascular dysfunction. These therapies provide transient improvement in vision and are often uncomfortable to persons with diabetic macular edema and fina…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Snake venom protein tested as cancer treatment in humans
Disease control Not yet recruitingThe primary objective of the study is to assess whether human subjects can be made tolerant to intravenously administered Crotoxin and achieve higher and more therapeutically effective doses levels without the previously reported adverse effects associated with bolus i.m. adminis…
Phase: PHASE1 • Sponsor: Celtic Biotech Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a remote nurse boost HIV prevention at kenyan pharmacies?
Prevention Not yet recruitingIn this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continu…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Glowing dye may save surgical flaps in head and neck cancer patients
Disease control Not yet recruitingThis is a prospective multicentre randomised controlled trial evaluating whether intraoperative indocyanine green (ICG) fluorescence angiography improves outcomes in head and neck free flap reconstruction compared with standard clinical assessment of flap perfusion. Adult patient…
Phase: PHASE4 • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a monthly shot replace weekly diabetes injections?
Disease control Not yet recruitingThis is a randomized, open-label, multi-center, active-controlled Phase 2 clinical trial to evaluate the efficacy and safety of switching from once-weekly dulaglutide to PG-102(MG12) in patients with type 2 diabetes mellitus receiving stable dulaglutide therapy. The treatment pe…
Phase: PHASE2 • Sponsor: ProGen. Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Migraine relief may sharpen the mind: study investigates cognitive benefits of preventive therapies
Knowledge-focused Not yet recruitingIn chronic migraine, we routinely use innovative treatments such as peri-cranial injections of botulinum toxin type A according to the PREEMPT protocol, or intravenous Eptinezumab, both targeting the Calcitonin Gene-Related Peptide (CGRP). We observe significant improvement in 70…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Experimental drug aims to halt liver failure in cirrhosis patients
Disease control Not yet recruitingPhase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients with Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure
Phase: PHASE2 • Sponsor: Genfit • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New surgical tool aims to suck away kidney stones faster and safer
Disease control Not yet recruitingA single-arm, multicenter, international, prospective interventional study designed to evaluate the safety and performance of an investigational device during retrograde intrarenal surgery for the treatment of renal calculi.
Phase: NA • Sponsor: Ventaris Surgical Incorporated • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Promising drug cocktail targets tough childhood cancers
Disease control Not yet recruitingHEM-iSMART is a master protocol which investigates multiple investigational medicinal products in children, adolescents and young adults (AYA) with relapsed/refractory (R/R) ALL and LBL. Sub-protocol E is a phase I/II trial evaluating the safety and efficacy of capivasertib + ven…
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
Can an old alcohol-dependence drug help the immune system fight brain cancer?
Disease control Not yet recruitingThis research study is for participants with glioblastoma. It can cause a tumor immunosuppression which helps myeloid cells that can stop T-cell function. Disulfiram is a drug that has been used in treating other disorders, but this study will examine if disulfiram can help make …
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New trial aims to stop stomach bleeding before it starts
Disease control Not yet recruitingA number of treatment modalities are currently in use for gastric variceal bleeding (GVB). Balloon-occluded, plug-assisted, and coil-assisted retrograde transvenous obliteration (RTO) procedures are described in the literature as treatments for GVB after a bleeding episode occurs…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC